A large-scale, federally funded quality improvement program developed in collaboration with infection prevention experts at the Johns Hopkins Armstrong Institute…
An investigational EGFR x HER3 antibody-drug conjugate demonstrated promising efficacy with a tolerable safety profile in patients with previously treated…
